Chemical industry – Page 73
-
Business
AstraZeneca to buy ZS Pharma for ion-balance drugs
$2.7 billion deal anticipates regulatory success for drug candidate under review
-
Business
Samsung to sell chemicals businesses to Lotte
Korean conglomerate Lotte will pay £1.7 billion for stake in Samsung’s chemicals businesses
-
Business
Dow backs off of Kuwaiti joint ventures
EQUATE will acquire MEGlobal as part of Dow’s restructuring of its Kuwaiti joint ventures
-
Business
Shire to buy rare disease specialist Dyax
Deal includes an already-approved drug for angioedema and an experimental antibody treatment
-
Business
Bristol-Myers Squibb to buy Cardioxyl for heart drug
Deal worth up to $2bn gives BMS full rights to Phase II clinical candidate
-
Business
Job cuts at Daiichi, Perrigo and Cabot
Staff reductions aimed at cutting costs or, in Perrigo’s case, fending off a takeover bid
-
NewsMalaria vaccine pilot studies recommended by WHO
GlaxoSmithKline’s RTS,S vaccine must undergo further testing before being rolled out, says World Health Organization panel
-
Business
Biogen to cut 800 jobs worldwide
US biotech is reducing its workforce by 11% and cancelling several R&D programmes to cut costs
-
Business
Nine dead in China plant blast
Explosion in Shandong province latest of several incidents in Chinese chemical plants
-
Business
BMS agrees $1.7bn immuno-oncology collaboration
Deal strengthens cancer antibody alliance with Five Prime Therapeutics
-
BusinessRaising industry’s voice
Canadian companies need to engage more with government to safeguard competitiveness while improving sustainability
-
BusinessDuPont found liable for cancer case
US court orders firm to pay $1.6m in damages for disease linked to contaminated water supply
-
Business
Monsanto plans 2600 layoffs
Sales losses prompt agrochemical giant to slash workforce by 12% over the next two years
-
Business
EPA fines Mosaic Fertilizer over hazardous waste handling
US Environmental Protection Agency agrees settlement contract including $8m penalty and $800m in investments
-
BusinessControversial new trade deal finalised
The Trans-Pacific Partnership could raise the price of medicines, especially in developing nations
-
Business
Bristol-Myers Squibb fined for alleged Chinese bribes
US Securities and Exchange Commission accepts $14m settlement for charges covering the last five years
-
Business
Safety board fills in details of deadly DuPont leak
In interim investigation has outlined the events and safety failings leading to a methyl mercaptan release that killed four workers
-
Opinion
Human capital
Business leader: Incubators and hubs for small and medium-sized enterprises are all the fashion
-
OpinionWhat the market will bear?
Martin Shkreli’s monopolising model poses some uncomfortable questions for the pharma industry, says Derek Lowe